‘Unsafe sexual practices account for 68% of AIDS cases in Mizoram'
Aizawl:
Unsafe sexual practices
account for 68% of HIV/AIDS infections, while 30% cases stem from intravenous drug users (IDUs) sharing contaminated syringes and needles, said Dr Jane R. Ralte, project director of
Mizoram State AIDS Control Society
(MSACS),
During a meeting of the Lunglei District AIDS Prevention and Control Committee (DAPCC) on Monday, chaired by deputy commissioner Navneet Mann, Ralte advocated for HIV awareness education to commence at the middle school level.
She reported that in the 2025-2026 fiscal year, amongst 59,243 general HIV screenings, 1,851 individuals (3.12%) tested positive in Mizoram. Additionally, from 18,425 Antenatal Care (ANC) tests conducted, 106 cases (0.58%) were confirmed positive during the same period.
The meeting's reports indicated that in Lunglei district during 2025-2026, out of 6,373 general screenings, 128 people (1.93%) tested positive for HIV.
Of these, 84 contracted through sexual transmission and 38 through shared contaminated needles amongst IDUs. The ANC testing revealed 7 positive cases (0.37%) from 1,885 screenings. Age distribution of the 128 positive cases showed 55 individuals aged 25-34, 39 aged 35-49, 15 aged 15-24, and 14 above 50 years.
Lunglei district has witnessed a declining trend in HIV cases amongst both general and ANC clients since 2020-2021.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Buy Brass Idols - Handmade Brass Statues for Home & Gifting
Luxeartisanship
Buy Now
Undo
Over the past 18 years since 2008, 2,156 HIV infections were recorded, with 1,473 individuals receiving Antiretroviral Therapy (ART), whilst 446 persons succumbed to full-blown AIDS.
Aizawl: Unsafe sexual practices account for 68% of HIV/AIDS infections, while 30% cases stem from intravenous drug users (IDUs) sharing contaminated syringes and needles, said Dr Jane R. Ralte, project director of Mizoram State AIDS Control Society (MSACS),
During a meeting of the Lunglei District AIDS Prevention and Control Committee (DAPCC) on Monday, chaired by deputy commissioner Navneet Mann, Ralte advocated for HIV awareness education to commence at the middle school level.
She reported that in the 2025-2026 fiscal year, amongst 59,243 general HIV screenings, 1,851 individuals (3.12%) tested positive in Mizoram. Additionally, from 18,425 Antenatal Care (ANC) tests conducted, 106 cases (0.58%) were confirmed positive during the same period.
The meeting's reports indicated that in Lunglei district during 2025-2026, out of 6,373 general screenings, 128 people (1.93%) tested positive for HIV.
Of these, 84 contracted through sexual transmission and 38 through shared contaminated needles amongst IDUs. The ANC testing revealed 7 positive cases (0.37%) from 1,885 screenings. Age distribution of the 128 positive cases showed 55 individuals aged 25-34, 39 aged 35-49, 15 aged 15-24, and 14 above 50 years.
Lunglei district has witnessed a declining trend in HIV cases amongst both general and ANC clients since 2020-2021. Over the past 18 years since 2008, 2,156 HIV infections were recorded, with 1,473 individuals receiving Antiretroviral Therapy (ART), whilst 446 persons succumbed to full-blown AIDS.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
A shot of hope
New HIV medicine is powerful – but can everyone afford it? A new medicine called lenacapavir has just been approved in the US to help stop people from getting HIV, the virus that causes AIDS. That's big news! Even though fewer people are getting HIV today than in the 1990s, around 13 lakh (1.3 million) people still get infected every year around the world. Lenacapavir is special because you only need two shots a year – not a pill every day like older medicines. That's great for people who forget daily pills or feel embarrassed taking them. And it's almost 100% effective at stopping HIV in adults and teens. But there's a big problem: the cost. In the US, it sells for over ₹23 lakh a year! Even rich countries find that hard to afford. The company that makes it, Gilead, is working with more than 100 poorer countries to help them make cheaper versions. Still, many African countries where HIV is most common may struggle to get it to the people who need it most. Scientists have been trying to create a proper HIV vaccine for decades, but HIV keeps mutating – changing too fast for one shot to work. New mRNA vaccines (like the ones used for Covid) are being tested, but funding cuts in the US have slowed down this research. That's why lenacapavir gives us hope. But hope only works if everyone, everywhere, can afford it. Facebook Twitter Linkedin Email Disclaimer Views expressed above are the author's own.
Time of India
2 hours ago
- Time of India
Dose of hope
Times of India's Edit Page team comprises senior journalists with wide-ranging interests who debate and opine on the news and issues of the day. To really help, new HIV vax has to be made cheap A pill to treat multidrug-resistant HIV, lenacapavir, has been approved by US drug regulator FDA as a preventive vaccine. This is a huge deal – incidence of HIV may have declined since 1990s but even today about 13L people globally are infected by the virus every year. But its price is an obstacle. Sold for $28,218 per year in US, it's prohibitive even for high-income nations. Pharma company Gilead that manufactures lenacapavir has reportedly tied up with over 100 middle- and low-income countries for manufacture of generics pending approvals. But access likely will still be tricky for poorer African countries that bear the HIV burden. Drugs to prevent HIV transmission have been around almost a decade, but a daily dosage regimen makes these unreliable. People forget and there's the stigma/doubt in partners that a daily dose is preventive. Lenacapavir needs to be taken just twice a year. Its long-lasting effect in preventing infection – almost 100% in adults and adolescents – is thus the best bet today. Also because HIV research in US bears the additional burden of Trump administration's slashed funds. An effective vaccine for HIV has been elusive for decades because of its rapid mutations. Several mRNA vaccines, like those developed for Covid and considered the most promising, are in clinical trials. But since Jan, under Trump's health secretary Bob Kennedy Jr, NIH stopped funding hundreds of such HIV vaccine-related research. This is what makes repurposed lenacapavir a lifeline, provided it's made affordable. Facebook Twitter Linkedin Email This piece appeared as an editorial opinion in the print edition of The Times of India.
Time of India
7 hours ago
- Time of India
Tripura CM mulls sex education in Class VIII-XII curriculum
Agartala: Tripura CM on Friday said the state govt is considering the introduction of sex education in the curriculum for students in Classes VIII to XII. Speaking at the legislative forum in the state assembly, Saha emphasised the importance of this initiative, stating, "We are considering incorporating sex education and HIV/AIDS awareness in the school curriculum in Class VIII-XII. Tired of too many ads? go ad free now This is not a matter of controversy, it is a necessity." He also encouraged community involvement, suggesting that MLAs could allocate funds to support HIV/AIDS patients. Saha highlighted the equal impact of HIV/AIDS on both boys and girls and stressed the importance of engaging youth in sports, cultural activities, and other creative pursuits to steer them away from drug addiction and reduce their vulnerability to HIV/AIDS. He said Tripura was the first state in India to introduce Red Ribbon Clubs in schools and plans to create youth ambassadors to lead campaigns against drug abuse. Expressing concern over the rising number of HIV/AIDS cases and injecting drug users, particularly among teenagers, Saha said an average of 120 new HIV infections are reported each month in the state, despite preventive efforts by the state AIDS Control Society. In response to a proposal by Congress legislator Sudip Roybarman, the chief minister supported the idea of adding a dedicated chapter on sex education and HIV/AIDS to the school curriculum to raise awareness among the most vulnerable age group. Additionally, he suggested that each MLA could allocate Rs 1 lakh per year from their area development fund for initiatives against drugs and HIV.
